DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Deep Vein Thrombosis (DVT) - Pipeline Review, H1 2017" report to their offering.
Deep Vein Thrombosis (DVT) - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Deep Vein Thrombosis (DVT) (Cardiovascular), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
The Deep Vein Thrombosis (DVT) (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Deep Vein Thrombosis (DVT) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase I and Preclinical stages are 2, 1 and 3 respectively. Similarly, the Universities portfolio in Preclinical stages comprises 1 molecules, respectively.
Deep Vein Thrombosis (DVT) (Cardiovascular) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.
Key Topics Covered:
- Deep Vein Thrombosis (DVT) - Overview
- Deep Vein Thrombosis (DVT) - Therapeutics Development
- Pipeline Overview
- Pipeline by Companies
- Pipeline by Universities/Institutes
- Products under Development by Companies
- Products under Development by Universities/Institutes
- Deep Vein Thrombosis (DVT) - Therapeutics Assessment
- Assessment by Target
- Assessment by Mechanism of Action
- Assessment by Route of Administration
- Assessment by Molecule Type
- Deep Vein Thrombosis (DVT) - Companies Involved in Therapeutics Development
- 3SBio Inc
- Dong-A Socio Holdings Co Ltd
- F. Hoffmann-La Roche Ltd
- Generex Biotechnology Corp
- Laboratorios Farmaceuticos Rovi SA
For more information about this report visit http://www.researchandmarkets.com/research/8ldrhq/deep_vein